Zdrowie i gospodarka · 20/05/2004
FDA Establishes Docket for Comments on Prescription Drug Accessibility for Blind and Visually-Impaired Individuals
The FDA is seeking public input on making prescription pharmaceutical information accessible to blind and visually-impaired individuals, as mandated by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
Source: Federal Register — Food and Drug AdministrationOpen original release →